Search

everythinglearnresearchcommunity

for

Search:↓

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

A 12-year-old boy had severe shingles and skin damage after a stem-cell transplant.

Alopecia areata involves unique activation of certain immune cells.

Autogenic PRP improves graft viability more than xenogenic PRP, but both are effective.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

BST2 protein and certain T cells increase in early alopecia areata.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Alopecia universalis from alemtuzumab in multiple sclerosis can be reversed with specific treatments.

B cells can both help and hinder the body's defense against melanoma.

A man developed a skin cancer called folliculotropic mycosis fungoides after a kidney transplant.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

Long-standing benign tumors can become cancerous, especially in people with weakened immune systems.

Acute leukemias with the Philadelphia chromosome may be biphenotypic, and identifying this is important for proper treatment.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Transplanting body hair helped repigment and treat a man's vitiligo.

Skin changes help detect graft-versus-host reaction early after bone marrow transplants.

Vinblastine can help treat childhood ITP but may cause reversible side effects.

Body hair can be used for hair transplants when scalp hair is insufficient.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Isolated limb perfusion is a safe and effective treatment for limb melanoma.

Autoimmune reactions may cause both alopecia areata and HAM.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.